NATHAN FAWBUSH: Open Payments
NPI 1811401193 · SCOTT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 14 payments from 8 companies in 2025. Trend: 2023 $72 · 2024 $306 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 4 | $100 |
| Lilly USA, LLC | 3 | $62 |
| ABBVIE INC. | 2 | $34 |
| Boston Scientific Corporation | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: NUZYRA, MOUNJARO, UBRELVY, XHANCE, WATCHMAN FLX, FREESTYLE LIBRE 3, ZEPBOUND, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
